HR5169

1) WHAT HAPPENED: HR5169, the 'Retire through Ownership Act', was reported (amended) by the House Committee on Education and Workforce on January 14, 2026, and placed on the Union Calendar (Calendar No. 383). The bill clarifies ERISA's adequate consideration definition, allowing ESOP fiduciaries to safely rely on independent valuations adhering to IRS Revenue Ruling 59-60 methodology for non-publicly traded securities. It was introduced by Rep. Allen (R-GA) and has 4 cosponsors. The committee vote was 35-0, indicating strong bipartisan support. The bill is at the House floor stage; a companion bill (S2403) is held at the Senate desk. 2) THE MONEY TRAIL: There is no direct funding authorized or appropriated by this bill. It is a regulatory clarification that reduces fiduciary liability. The economic impact comes from removing a barrier to ESOP adoption. ESOP transactions typically require valuation and advisory fees ranging from $50,000 to $500,000+ per engagement, creating revenue opportunities for advisory firms. The Congressional Budget Office will likely score this as negligible direct federal spending because it does not authorize appropriations. 3) STRUCTURAL WINNERS AND LOSERS: Winners are advisory firms with dedicated ESOP practices: Aon ($AON) provides retirement consulting and ESOP valuation services; Omnicom ($OMC) owns specialized advisory firms that conduct ESOP appraisals and transactions. The bill is neutral or negative for litigation-focused firms that currently benefit from fiduciary breach lawsuits related to valuation disputes. Pure-play ESOP administration technology firms (mostly private) would also benefit from increased adoption. 4) REAL MARKET DATA: $AON trades at $322.49, with a 30-day change of -0.48% and 7-day change of -0.33%. $OMC trades at $76.19, with a 30-day change of +1.16% and 7-day change of -0.82%. Both stocks are near the lower end of their 52-week ranges ($AON: $304.59-$381; $OMC: $66.33-$87.17), suggesting the market has not priced in any ESOP-related catalyst. The bill's floor prospects could provide a modest near-term catalyst. 5) TIMELINE: The bill must pass the full House, then the Senate (companion S2403 is held at the desk), and be signed by the President. Given the 35-0 committee vote and bipartisan sponsorship, House passage is likely in the current session. Senate timing depends on floor scheduling. The bill would take effect for valuations made on or after enactment.